When the half-maximal inhibitory concentration (IC50) was calculated, we observed that a higher dose of the drugs was needed for breast cancer cell lines expressing COMP to achieve effect similar to the mock cells (Fig. S2). The gene discussed is COMP; the disease is breast cancer.